256 results on '"MIETTUNEN, PAIVI"'
Search Results
2. Distinct phenotypes of multisystem inflammatory syndrome in children: a cohort study
3. Phenotypic variability and disparities in treatment and outcomes of childhood arthritis throughout the world: an observational cohort study
4. Relationship of Fatigue, Pain Interference, and Physical Disability in Children Newly Diagnosed With Juvenile Idiopathic Arthritis
5. Non-invasive biomarkers of disease activity and organ damage in ANCA-associated vasculitis: a systematic review
6. A decade of progress in juvenile idiopathic arthritis treatments and outcomes in Canada: results from ReACCh-Out and the CAPRI registry
7. Vertebral body reshaping after fractures: an important index of recovery in glucocorticoid-treated children
8. Development and Initial Validation of the Macrophage Activation Syndrome/Primary Hemophagocytic Lymphohistiocytosis Score, a Diagnostic Tool that Differentiates Primary Hemophagocytic Lymphohistiocytosis from Macrophage Activation Syndrome
9. Clinical Characteristics of Adolescents With Juvenile Idiopathic Arthritis Transitioning to Adult Rheumatology Care in Canada: Results From the CAPRI Registry.
10. The Canadian English and French versions of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)
11. Patient factors associated with waiting time to pediatric rheumatologist consultation for patients with juvenile idiopathic arthritis
12. Additional file 1 of Distinct phenotypes of multisystem inflammatory syndrome in children: a cohort study
13. Chronic recurrent multifocal osteomyelitis with a comprehensive approach to differential diagnosis of paediatric skull pain
14. Vertebral Body Reshaping after Fractures: An Important Index of Recovery in Glucocorticoid-Treated Children
15. Canadian Rheumatology Association Recommendations for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis-associated Uveitis
16. Trajectories of pain severity in juvenile idiopathic arthritis: results from the Research in Arthritis in Canadian Children Emphasizing Outcomes cohort
17. Reductions in Bone Mineral Density Are Apparent Early in Children With Prevalent Osteonecrosis Lesions Following Leukemia Therapy.
18. Management of pediatric generalized pustular psoriasis using biologics: An evidence-based review
19. Purpura, petechiae, and bullae as first signs of juvenile granulomatosis with polyangiitis
20. The risk and nature of flares in juvenile idiopathic arthritis: results from the ReACCh-Out cohort
21. Development and Initial Validation of the Macrophage Activation Syndrome/Primary Hemophagocytic Lymphohistiocytosis Score, a Diagnostic Tool that Differentiates Primary Hemophagocytic Lymphohistiocytosis from Macrophage Activation Syndrome
22. A rare case of suspected lupus erythematous panniculitis as the presenting skin feature of juvenile dermatomyositis: A case report
23. 2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A European League Against Rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative
24. The outcomes of juvenile idiopathic arthritis in children managed with contemporary treatments: results from the ReACCh-Out cohort
25. Incident Vertebral Fractures in Children With Leukemia During the Four Years Following Diagnosis
26. Canadian Rheumatology Association Recommendations for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis.
27. Acceptability of an Adolescent Self‐Management Program for Juvenile Idiopathic Arthritis
28. Canakinumab improves patient-reported outcomes in children and adults with autoinflammatory recurrent fever syndromes: results from the CLUSTER trial
29. Widespread Osteonecrosis in Children With Leukemia Revealed by Whole-body MRI
30. Clinical Features, Treatment, and Outcome of Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A Multinational, Multicenter Study of 362 Patients
31. Osteoporotic Fractures and Vertebral Body Reshaping in Children With Glucocorticoid-Treated Rheumatic Disorders
32. Development and validation of the Kids Disability Screen for children with juvenile idiopathic arthritis: results from the CAPRI Registry.
33. Incident vertebral fractures 12 months following glucocorticoid initiation in children with rheumatic disorders
34. Corticosteroid related changes in body mass index in children and adolescents with rheumatic diseases
35. A154: Glucocorticoid Therapy and the Risk of Incident Vertebral Fracture in Children with Rheumatic Disorders
36. Therapeutic approaches for the treatment of renal disease in juvenile systemic lupus erythematosus: an international multicentre PRINTO study
37. The PRINTO criteria for clinically inactive disease in juvenile dermatomyositis
38. Successful treatment of severe paediatric rheumatic disease-associated macrophage activation syndrome with interleukin-1 inhibition following conventional immunosuppressive therapy: case series with 12 patients
39. Anakinra as First-Line Disease-Modifying Therapy in Systemic Juvenile Idiopathic Arthritis: Report of Forty-Six Patients From an International Multicenter Series
40. Novel use of Autoinflammatory Diseases Activity Index (AIDAI) captures skin and extracutaneous features to help manage pediatric DITRA: A case report and a proposal for a modified disease activity index in autoinflammatory keratinization disorders
41. Macrophage activation syndrome in juvenile systemic lupus erythematosus: A multinational multicenter study of thirty-eight patients
42. Predictors of Early Inactive Disease in a Juvenile Idiopathic Arthritis Cohort: Results of a Canadian Multicenter, Prospective Inception Cohort Study
43. Dramatic Response of Scarring Scalp Discoid Lupus Erythematosus (DLE) to Intravenous Methylprednisolone, Oral Corticosteroids, and Hydroxychloroquine in a 5-Year-Old Child
44. Impact of the COVID-19 pandemic on juvenile idiopathic arthritis presentation and research recruitment: results from the CAPRI registry.
45. Acceptability of an Adolescent Self‐Management Program for Juvenile Idiopathic Arthritis.
46. Consensus Treatment Plans for Chronic Nonbacterial Osteomyelitis Refractory to Nonsteroidal Anti-Inflammatory Drugs and/or with Active Spinal Lesions
47. Feasibility and safety of a 6-month exercise program to increase bone and muscle strength in children with juvenile idiopathic arthritis
48. Severe bilateral Legg-Calvé-Perthes resolved with pamidronate in combination with casts, physiotherapy and adductor tenotomy: a pictorial essay over 11 years
49. Use of intravenous pamidronate in pediatric acute lymphoblastic leukemia patients with osteonecrosis (ON) results in reduced pain and improved radiologic outcome of ON lesions: Long- term follow-up over 15-years
50. A prospective study of 17 consecutive pediatric patients with chronic non-bacterial osteomyelitis treated with intravenous pamidronate over a 15 year period at a single center reveals excellent clinical and radiologic outcome initially and after flare
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.